0 of 12 questions completed
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
0 of 12 questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Multiple myeloma is a disease associated with:
High-risk multiple myeloma is associated with:
Which patient populations have a higher incidence of multiple myeloma?
TRUE or FALSE, MGUS or smoldering myeloma are characterized as symptomatic multiple myeloma?
The UIFE and SIFE laboratory techniques measure:
Which of the following is a monoclonal antibody approved for treatment of relapsed myeloma?
In patients with early relapse, which combinations have the highest response rates and superior progression free survival (PFS)?
What grade of peripheral neuropathy would require discontinuing bortezomib?
What should be the duration of bisphosphonate therapy in patients receiving first-line antimyeloma therapy?
The incidence of peripheral neuropathy is lower with Bortezomib (Velcade®) administered IV vs administered subcutaneously:
Risk factors for thromboembolic events include all of the following except:
All of the following are true regarding myeloma patients and varicella zoster virus (VZV), except: